Nautilus Biotechnology @nautilus.bio · Jan 28 Nautilus Biotechnology; Weill Cornell Medicine-Qatar; and The Michael J. Fox Foundation for Parkinson’s Research today announced a research collaboration to study the connection between the alpha-synuclein protein and Parkinson’s disease. Learn more: www.globenewswire.com/news-release...
0 likes 1 replies
?
Replies
Supported by a $1.6 million research grant from MJFF, the high-impact project combines the Lashuel lab’s expertise in the molecular and chemical biology of neurodegeneration with Nautilus’ next-generation platform for measuring proteins and their proteoforms at single-molecule resolution.